Can Losing Weight Improve Erectile Function? What the Trials Found

Search whether losing weight helps erectile dysfunction and every result on page one traces back to the same randomised trial — published in JAMA in 2004.

It is a good trial. It is also twenty-two years old, and it is not the only evidence any more. A meta-analysis pooling five randomised trials was published in 2022, and a meta-analysis of 45 studies covering more than 42,000 men settled the underlying association in 2020. Neither appears anywhere on that first page.

Here is the current picture, including the trial where a large amount of weight came off and nothing happened.

The Short Answer

Weight loss produces a real but modest average improvement in erectile function in men who are overweight or obese.

A 2022 meta-analysis of randomised controlled trials found a mean difference of +1.99 points on the IIEF erectile function questionnaire between men in weight-loss programmes and controls.

It is best understood as an evidence-supported lifestyle intervention that produces a modest average improvement — and, in one carefully selected trial, moved about a third of men into the normal range — rather than something that resolves erectile dysfunction universally.

The association it builds on is well established: men with obesity have roughly 46% higher adjusted odds of erectile dysfunction than normal-weight men, across 45 studies and 42,489 participants.

First, the Association

Before asking whether losing weight helps, it is worth being precise about how strong the link actually is.

A 2020 systematic review and meta-analysis in Reviews in Endocrine and Metabolic Disorders screened 3,409 studies and pooled 45 articles covering 42,489 men, mean age 55. Compared with normal-weight men:

• Overweight men: odds ratio 1.31 (95% CI 1.13–1.51)
• Men with obesity: odds ratio 1.60 (95% CI 1.29–1.98)
• Men with obesity, adjusted for confounders: odds ratio 1.46 (95% CI 1.24–1.72)

Men with erectile dysfunction also had a higher average BMI than men without, by 0.769 kg/m² (95% CI 0.565–0.973).

Two caveats travel with these numbers. Heterogeneity between studies was high throughout — the I² statistic ran from 72% to 79% for the odds ratios, meaning the individual studies disagreed with each other considerably. And these are observational, largely cross-sectional data. They establish that excess weight and erectile dysfunction occur together more often than chance; they do not establish that one causes the other.

That distinction is exactly why the intervention trials matter.

What the Randomised Trials Found

A 2022 meta-analysis in Andrologia pooled five randomised controlled trials covering 619 participants, searching to March 2021, with change in IIEF score as the primary outcome.

Result: a mean difference of +1.99 IIEF points favouring weight loss (p < 0.01). The authors concluded that losing weight "could serve as an adjuvant therapy for ED."

Two things about that figure deserve attention.

First, the published abstract does not report confidence intervals or a heterogeneity statistic for that estimate, so the precision behind it cannot be assessed from the abstract alone. The same analysis reported large pooled differences in body weight and BMI between intervention and control groups, which suggests the five trials varied considerably in how aggressive their interventions were.

How to read a two-point change

The pooled average improvement was modest. For context, the established analysis of minimal clinically important differences in the six-item IIEF erectile function domain — derived by Rosen and colleagues from 17 randomised tadalafil trials covering 3,345 patients — put the overall threshold at 4 points, varying significantly with baseline severity: 2 points in mild erectile dysfunction, 5 in moderate, 7 in severe.

That benchmark is context, not a direct test. It was derived for the 6-item erectile function domain, which runs from 0 to 30; several weight-loss trials used the 5-item IIEF-5, which runs on a different scale entirely, so a point on one is not a point on the other. The authors of the MCID analysis also noted that their results needed replication outside pharmacological trials, and weight-loss studies are exactly the setting they had in mind.

So the honest reading is that the pooled improvement is real, statistically significant, and small relative to what men typically notice — without claiming the comparison is exact.

The trial the whole first page rests on

The landmark study is Esposito and colleagues, published in JAMA in 2004. It randomised 110 obese men aged 35 to 55 — deliberately selected to be free of diabetes, hypertension and high cholesterol — to an intensive lifestyle programme or general healthy-eating advice, and followed them for two years.

• BMI fell from 36.9 to 31.2 in the intervention group, against 36.4 to 35.7 in controls (p < 0.001)
• IIEF scores rose from 13.9 to 17 in the intervention group and stayed flat in controls, moving from 13.5 to 13.6 (p = 0.89)
• 17 men in the intervention group reached a normal IIEF score of 22 or above, against 3 controls (p = 0.001)

The authors summarised it as improvement in about one third of obese men.

That last figure is the strongest result in this literature, and it comes with a condition attached. The population was chosen to be metabolically clean — no diabetes, no hypertension, no high cholesterol — which is part of why its effect looks larger than the pooled figure, and why one third should not be read as a general response rate. A man whose erectile difficulty also involves diabetes or vascular disease is not the man this trial studied.

The trial that mostly shows something different

The Look AHEAD trial examined intensive lifestyle intervention in older men with type 2 diabetes — a population Esposito excluded. Among 372 men at baseline and 306 at one year, the intervention group lost 9.9% of body weight against 0.6% in controls.

Erectile function improved more in the intervention arm, from 17.3 to 18.6 against 18.3 to 18.4 (p = 0.04) — but the difference was no longer statistically significant after adjusting for baseline scores (p = 0.06).

The categorical results are clearer, and they point at something specific. 22% of the intervention group improved, against 23% of controls — essentially identical. But 8% of the intervention group got worse, against 20% of controls (p = 0.006).

So Look AHEAD did not meaningfully increase the proportion of men who improved; it substantially reduced the proportion whose erectile function worsened over the year. The authors described the intervention as mildly helpful in maintaining erectile function. That is a real benefit, and it is a different claim from improvement.

A third randomised trial, with a small effect

The SHED-IT trial randomised 145 overweight and obese men to a minimal-contact weight-loss programme or a waiting list. At six months, the intention-to-treat analysis found an effect on IIEF-5 of +1.4 points (95% CI 0.3–2.4), a small effect size of 0.32.

That is close to the pooled estimate, from a much lighter-touch intervention.

The Trial Where a Large Weight Loss Changed Nothing

A 2010 trial in the International Journal of Andrology followed morbidly obese men over 24 months, at three timepoints. Ten men had four months of lifestyle modification followed by gastric bypass; ten had follow-up only.

By 24 months, the surgical group showed significant improvement against the comparison group in IIEF-5 (p = 0.0224), total testosterone (p = 0.0043) and free testosterone (p = 0.0149).

The part almost nobody quotes is what happened in the first four months. During the lifestyle-modification phase, before any surgery, mean BMI in that group fell by 12.6 units (p < 0.0001) — an enormous reduction. Over the same interval, the study reports no changes at all in erectile function or hormones.

The authors' own conclusion is blunt: lifestyle modification "impacted BMI without hormonal or sexual impact in morbidly obese" men.

This cuts against the simple story, and it should be reported that way. A very large amount of weight came off, and the measured sexual and hormonal outcomes did not move until after surgery.

Two limits on how far that can be pushed. The trial enrolled twenty men in total, which is far too small to establish that lifestyle-induced weight loss cannot improve these outcomes in severe obesity — a real effect could easily hide in a sample that size. And its abstract reports significance levels without effect sizes or confidence intervals. But it is a genuine caution against assuming that weight coming off automatically means erectile function improving.

Why Testosterone Is Not the Established Explanation

The most common mechanistic story is that weight loss raises testosterone, and higher testosterone improves erections.

The first half of that is well supported. Weight loss reliably raises testosterone in men who start overweight or obese — pooled increases of about 2.5 nmol/L after dietary weight loss and 7.2 nmol/L after bariatric surgery. Related reading: Does Losing Weight Increase Testosterone? What the Meta-Analyses Show.

The second half — that the hormonal change is what drives the erectile improvement — has not been demonstrated. The 2010 surgical trial's authors wrote that the hormonal change "could justify" the improvement in erectile function, which is an inference offered rather than a mediation analysis performed. No study located for this article measured weight change, testosterone and erectile function together and showed testosterone carrying the effect. And the same trial's four-month phase, where BMI fell sharply while both hormones and erectile scores stayed flat, sits awkwardly with a simple hormonal explanation.

Other pathways are equally available and equally unproven: improved vascular function, better blood pressure and glycaemic control, reduced systemic inflammation, better sleep, and changes in mood or body image. Esposito's trial found that changes in BMI, physical activity and C-reactive protein — an inflammation marker — were each independently associated with the change in erectile function, which points to more than one mechanism operating.

What About Waist Size Versus BMI?

It is often claimed that waist circumference predicts erectile dysfunction better than BMI. The most recent review of this question does not support that claim as stated.

A 2025 systematic review in Archives of Sexual Behavior examined eight obesity-related measurements across 14 studies. It concluded that BMI and waist circumference both "have limitations in evaluating ectopic deposition of adipose tissue," and advised that clinicians "should avoid using BMI as a sole indicator of obesity" — but it did not crown waist circumference, and it performed no pooled analysis.

The 2020 meta-analysis did find larger waists among men with erectile dysfunction, by 5.251 cm, but with a confidence interval running from 1.3 to 9.2 cm and heterogeneity at 96% — a spread too wide to be useful as a number.

The defensible summary is that both measures are associated with erectile dysfunction and neither has been shown to be the better predictor.

The Reason This Is Worth Raising With a Provider

Erectile dysfunction is treated in current guidance as a marker of cardiovascular risk, not only a sexual complaint.

The European Association of Urology's guideline on erectile dysfunction states that "ED should be considered a precursor of CVD, and more severe and longer standing ED yields greater risk," and that erectile dysfunction can improve the sensitivity of screening for asymptomatic cardiovascular disease in men with or without diabetes. Its recommendations are adapted from the Princeton IV consensus conference, published in 2024, whose own summary states that mounting evidence supports treating men with erectile dysfunction as being at risk for cardiac events until proven otherwise.

That is the strongest practical reason not to treat this as a problem to solve alone. Erectile dysfunction also arises from diabetes, medication effects, hormonal conditions, sleep disorders and depression — several of which travel alongside excess weight, and none of which weight loss addresses on its own. Related reading: Why Viagra or Cialis Sometimes Doesn't Work and Low Libido in Men: Causes, Testosterone and Treatment Options.

A licensed provider can evaluate the whole picture. Published averages cannot.

Frequently Asked Questions

Does losing weight help erectile dysfunction?

It helps modestly on average. A 2022 meta-analysis of five randomised controlled trials covering 619 men found a mean improvement of 1.99 points on the IIEF erectile function questionnaire compared with controls. Individual trials range from a small effect in a light-touch programme to about a third of men reaching a normal score in an intensive two-year trial with a carefully selected population.

Can losing weight cure erectile dysfunction?

Weight loss should not be presented as a guaranteed cure. In one highly selected randomised trial — obese men aged 35 to 55 with no diabetes, hypertension or high cholesterol — about a third of the intensive lifestyle group reached a normal erectile function score after two years, against 3 of 55 controls. Most of the evidence shows modest average improvement rather than universal resolution, and erectile dysfunction frequently has causes weight loss does not address.

Does being overweight cause erectile dysfunction?

The evidence shows a consistent association, not established causation. A 2020 meta-analysis of 45 studies and 42,489 men found men with obesity had 1.60 times the odds of erectile dysfunction compared with normal-weight men, or 1.46 times after adjusting for confounders; overweight men had 1.31 times the odds. These are observational data with high heterogeneity between studies.

How much weight do you need to lose to improve erections?

No trial establishes a threshold. The trials that produced the largest improvements also produced the largest weight losses, but erectile response varied substantially between individuals and depends on what is causing the problem in the first place. One trial found a 12.6-unit BMI reduction over four months with no measurable change in erectile function, which is a caution against assuming any particular amount guarantees a result.

Can losing belly fat improve erectile function?

Loss of excess body fat is associated with better erectile function in intervention studies, but the evidence does not establish abdominal fat loss specifically as the causal factor. Both BMI and waist circumference correlate with erectile dysfunction, and a 2025 review found neither has been shown to be the better predictor. No study isolated abdominal fat loss as a separate intervention, and fat loss cannot be directed to one area anyway.

Does weight loss work for men with diabetes?

The evidence is weaker there. In the Look AHEAD trial of men with type 2 diabetes, the improvement lost statistical significance once baseline scores were accounted for, and the same proportion improved in both arms — 22% against 23%. What the trial did show clearly is that far fewer men in the intervention group got worse, 8% against 20%. The clearest group-level effect was reduced deterioration rather than a higher proportion of men improving.

Is it the weight loss or the testosterone?

Unresolved. Weight loss does raise testosterone in men who are overweight or obese, but no study has shown that the hormonal change is what produces the erectile improvement. One small trial found a large BMI reduction with no change in either hormones or erectile scores, which does not fit a simple hormonal explanation. Improved vascular function, blood pressure, blood sugar, inflammation, sleep and mood are all plausible contributors.

Is waist size a better predictor than BMI?

Not according to the most recent review. A 2025 systematic review of obesity-related measurements found both BMI and waist circumference have limitations, advised against using BMI alone, and did not identify a superior single measure. The pooled waist difference between men with and without erectile dysfunction has a confidence interval too wide to be practically useful.

AmalfiDuo Sexual Wellness Programs

If you're exploring ways to support your sexual wellness, AmalfiDuo offers private, provider-guided care programs for adults. A licensed clinician reviews your health information to determine whether treatment is appropriate.

Explore Sexual Wellness Programs

A prescription is never guaranteed.

References

1. Li H, Xu W, Wang T, Wang S, Liu J, Jiang H. Effect of weight loss on erectile function in men with overweight or obesity: A meta-analysis of randomised controlled trials. Andrologia. 2022;54(1):e14250. PMID 34644814.
2. Pizzol D, Smith L, Fontana L, et al. Associations between body mass index, waist circumference and erectile dysfunction: a systematic review and meta-analysis. Reviews in Endocrine and Metabolic Disorders. 2020;21(4):657–666. PMID 32002782.
3. Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291(24):2978–2984. PMID 15213209.
4. Wing RR, Rosen RC, Fava JL, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. Journal of Sexual Medicine. 2010;7(1 Pt 1):156–165. PMID 19694925.
5. Collins CE, Jensen ME, Young MD, et al. Improvement in erectile function following weight loss in obese men: the SHED-IT randomized controlled trial. Obesity Research & Clinical Practice. 2013;7(6):e450–e454. PMID 24459689.
6. Reis LO, Favaro WJ, Barreiro GC, et al. Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial. International Journal of Andrology. 2010;33(5):736–744. PMID 20039972.
7. Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. European Urology. 2011;60(5):1010–1016. PMID 21855209.
8. EAU Guidelines on Sexual and Reproductive Health: Management of Erectile Dysfunction. European Association of Urology.
9. Köhler TS, Kloner RA, Rosen RC, et al. The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease. Mayo Clinic Proceedings. 2024;99(9):1500–1517. PMID 39115509.
10. Li T, Chen J, He B, Feng Q. Obesity-Related Anthropometric Indicators and Erectile Dysfunction: A Systematic Review. Archives of Sexual Behavior. 2025;54(7):2475–2489. PMID 40760403.
11. Ken-Dror G, Fluck D, Fry CH, Han TS. Meta-analysis and construction of simple-to-use nomograms for approximating testosterone levels gained from weight loss in obese men. Andrology. 2024;12(2):297–315. PMID 37345263.

This article is provided for general educational purposes only and is not a substitute for individualized medical advice, diagnosis or treatment. It reports pooled averages from published research, which describe groups rather than individuals, and does not recommend any particular diet, weight target or intervention. Erectile dysfunction has multiple possible causes, some of them serious, and current guidance treats it as a marker of cardiovascular risk warranting clinical assessment. Questions about sexual function should be discussed with a qualified healthcare professional. AmalfiDuo Journal articles are written by AmalfiDuo Editorial and are not medically reviewed — see our Editorial Policy.